The stability, accuracy, reproducibility, and predictive value of Sensititre MIC panels containing meropenem (Merrem) were evaluated by using National Committee for Clinical Laboratory Standards (NCCLS)-recommended American Type Culture Collection (ATCC) strains and 110 selected strains of rapidly growing and fastidious aerobes and anaerobes with various degrees of susceptibility to meropenem. The NCCLS-recommended agar dilution method was used as a standard reference method. Meropenem-containing Sensititre MIC panels were monitored for their stabilities at room temperature and reproducibilities over 24 months by using six ATCC strains.
Sensititre broth microdilution MIC panels provide a convenient and standardized susceptibility testing method for aerobic and anaerobic bacteria in clinical laboratories. Sensititre MIC panels, supplied by Radiometer America Inc., Westlake, Ohio, were developed for susceptibility testing of aerobes and anaerobes encountered in phase III North American clinical trials of meropenem (Merrem), a renal dehydropeptidase I-stable carbapenem, and imipenem in trials comparing imipenem-cilastatin.
Carbapenems such as imipenem as well as other 1-lactam antibiotics are known to be more labile than other drugs such as aminoglycosides and quinolones (1) . In addition, problems with the stability of imipenem have been reported previously. In 1985, Nickolai and colleagues (8) reported the rapid loss, within 2 weeks or less, of imipenem activity at 4 and -25°C. Problems with long-term storage (greater than 3 months) or MIC panels prepared in-house at these temperatures were also reported. More Table 1 ). The same quality control strains mentioned above in the stability testing section were used.
The media used for the agar dilution MIC For the microdilution MIC method, the media were Mueller-Hinton broth for aerobes, Wilkens-Chalgren broth for anaerobes, brucella broth supplemented with 5% laked sheep blood (Adams Scientific, Inc.) for fastidious anaerobes, Haemophilus Test Medium broth (Prepared Media Laboratories) for H. infiuenzae, and Mueller-Hinton broth supplemented with 2% laked horse blood for S. pneumoniae.
For determination of accuracy, all organisms were tested in parallel by using Sensititre panels and by agar dilution MIC methods. MICs were considered to be in numerical agreement when the MICs were identical or when the broth microdilution MICs were within ± I dilution of the agar dilution MICs. MICs were considered to be in disagreement when the broth microdilution MICs were -2 dilutions lower or higher than the agar dilution MICs. The method discrepancies were evaluated for their predictive significance, i.e., whether the results were interpreted as susceptible by one method and resistant by another method, using provisional susceptibility test interpretive criteria for meropenem, as follows: susceptible, MIC ' 4 pLg/ml; moderately susceptible or intermediate, MIC = 8 p.g/ml; and resistant, MIC -16 p.g/ml.
RESULTS Stability of meropenem. The Sensititre MIC results for all quality control strains generally remained within their respective provisional ranges over the 2-year monitoring period for meropenem (2, 3, 12, 13) . The MIC ranges were as follows: P. aeruginosa ATCC 27853, 0.25 to 1.0 p.g/ml; S. aureus ATCC 29213, 0.03 to 0.125 p.g/ml; E. faecalis ATCC 29212, 2.0 to 8.0 p.g/ml; B. fragilis ATCC 25285, 0.06 to 0.125 ,ug/ml; B. thetaiotaomicron ATCC 29741, 0.125 to 0.5 pLg/ml; and E. lentum ATCC 43055, 0.125 to 0.5 pg/ml. The provisional range for B. fragilis ATCC 25285 was modified to 0.06 to 0.25 pLg/ml by Zabransky (12) after the present study was completed. Occasional out-of-range MIC results were lower, but they were not higher than the provisional ranges.
All but one of the imipenem MIC results for all quality control strains remained within their respective NCCLS-recommended ranges over the 24-month period.
Comparison of susceptibility results. Table 1 shows the distribution of organisms tested. Fig.  1 ). For the American Type Culture Collection quality control strains, the Sensititre MICs of meropenem were in agreement with those presented in previous reports (2, 3, 12, 13 penem, and the lack of familiarity of panel manufacturers with meropenem, Sensititre MIC panels were comprehensively evaluated before and during use at centers conducting clinical trials. Acceptable MICs of meropenem and imipenem, i.e., 99% of the MICs for American Type Culture Collection quality control strains, were within the provisional quality control limits or established ranges, indicating an acceptable stability of the Sensititre MIC panels.
The Sensititre method provides a convenient and valid alternative to the NCCLS-recommended agar dilution methodology for the clinical laboratory. This is confirmed by several observations: (i) the predictive value of meropenem MICs for indicating susceptibility or resistance was greater than 90%; (ii) there were no major or very major interpretive errors, and only 5% of meropenem MICs were associated with minor interpretive errors; and (iii) there were no problems with the stability of meropenem under proper storage conditions. The Sensititre broth microdilution technique should be particularly useful for the evaluation of the susceptibilities to meropenem of potential pathogens likely to be recovered from mixed aerobic-anaerobic infections.
